Explore
13D/13G Activist Filings
119,232 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | PEPG | PepGen Inc. | Point72 Asset Management, L.P. | 13G/A | 3.0% | 2.1M |
| Nov 14, 2025 | IPST | Heritage Distilling Holding Company, Inc. | C/M Capital Master Fund, LP | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | CCCX | Churchill Capital Corp X/Cayman | Fort Baker Capital Management LP | 13G/A | 4.1% | 1.7M |
| Nov 14, 2025 | DNTH | Dianthus Therapeutics, Inc. | RA Capital Management, L.P. | 13G/A | 9.5% | 3.9M |
| Nov 14, 2025 | MBLY | Mobileye Global Inc. | Point72 Asset Management, L.P. | 13G/A | 2.8% | 6.0M |
| Nov 14, 2025 | GHRS | GH Research PLC | Terwey Theis H | 13G/A | 2.9% | 1.8M |
| Nov 14, 2025 | ZIP | ZIPRECRUITER, INC. | DISCIPLINED GROWTH INVESTORS INC /MN | 13G/A | 5.7% | 4.2M |
| Nov 14, 2025 | RNA | Avidity Biosciences, Inc. | RA Capital Management, L.P. | 13G/A | 5.9% | 8.6M |
| Nov 14, 2025 | AZTR | Azitra, Inc. | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/A | 2.6% | 273K |
| Nov 14, 2025 | SEI | SOLARIS ENERGY INFRASTRUCTURE, INC. | Encompass Capital Advisors LLC | 13G/A | 6.5% | 2.9M |
| Nov 14, 2025 | CDTX | Cidara Therapeutics, Inc. | Point72 Asset Management, L.P. | 13G/A | 6.2% | 1.6M |
| Nov 14, 2025 | AUUD | AUDDIA INC. | Cavalry Fund I LP | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | KURA | Kura Oncology, Inc. | BIOTECHNOLOGY VALUE FUND L P | 13G/A | 5.1% | 4.4M |
| Nov 14, 2025 | REPL | Replimune Group, Inc. | Point72 Asset Management, L.P. | 13G/A | 4.7% | 3.6M |
| Nov 14, 2025 | AVTX | Avalo Therapeutics, Inc. | RA Capital Management, L.P. | 13G/A | 9.9% | 1.4M |
| Nov 14, 2025 | VATE | INNOVATE Corp. | Whitefort Capital Management, LP | 13G/A | 7.8% | 1.1M |
| Nov 14, 2025 | HVII | Hennessy Capital Investment Corp. VII | Fort Baker Capital Management LP | 13G | 5.1% | 1.0M |
| Nov 14, 2025 | VCRM | Vanguard Municipal Bond Funds | KARPUS MANAGEMENT, INC. | 13G | 7.3% | 533K |
| Nov 14, 2025 | FGNX | FG Nexus Inc. | Point72 Asset Management, L.P. | 13G/A | 9.9% | 4.0M |
| Nov 14, 2025 | PGAC | PANTAGES CAPITAL ACQUSITION CORP | KARPUS MANAGEMENT, INC. | 13G/A | 8.1% | 887K |
| Nov 14, 2025 | AVTX | Avalo Therapeutics, Inc. | Point72 Asset Management, L.P. | 13G/A | 8.0% | 1.1M |
| Nov 14, 2025 | OXLCP | Oxford Lane Capital Corp. | KARPUS MANAGEMENT, INC. | 13G/A | 5.1% | 179K |
| Nov 14, 2025 | OXLCO | Oxford Lane Capital Corp. | KARPUS MANAGEMENT, INC. | 13G/A | 15.2% | 364K |
| Nov 14, 2025 | TENX | TENAX THERAPEUTICS, INC. | Lind Global Fund II LP | 13G/A | 8.8% | 442K |
| Nov 14, 2025 | OXLCN | Oxford Lane Capital Corp. | KARPUS MANAGEMENT, INC. | 13G/A | 23.4% | 560K |
| Nov 14, 2025 | AMLX | Amylyx Pharmaceuticals, Inc. | Point72 Asset Management, L.P. | 13G/A | 2.6% | 2.8M |
| Nov 14, 2025 | NXTC | NextCure, Inc. | Affinity Healthcare Fund, LP | 13G/A | 7.2% | 192K |
| Nov 14, 2025 | MNDR | Mobile-health Network Solutions | Teoh Pui Pui | 13D | 9.5% | 111K |
| Nov 14, 2025 | OXLCG | Oxford Lane Capital Corp. | KARPUS MANAGEMENT, INC. | 13G/A | 11.4% | 844K |
| Nov 14, 2025 | FIP | FTAI Infrastructure Inc. | Thebes Offshore Master Fund, LP | 13G/A | 3.3% | 3.8M |
| Nov 14, 2025 | N/A | Stone Point Credit Corp | GENERAL ELECTRIC PENSION TRUST | 13G/A | 6.0% | 4.0M |
| Nov 14, 2025 | ASST | Strive, Inc. | Citadel Advisors LLC | 13G/A | 10.0% | 41.3M |
| Nov 14, 2025 | MYN | BlackRock MuniYield New York Quality Fund, Inc. | KARPUS MANAGEMENT, INC. | 13G/A | 6.7% | 2.5M |
| Nov 14, 2025 | MUC | BlackRock MuniHoldings California Quality Fund, Inc. | KARPUS MANAGEMENT, INC. | 13G | 5.0% | 4.8M |
| Nov 14, 2025 | ANGO | ANGIODYNAMICS INC | Point72 Asset Management, L.P. | 13G/A | 6.2% | 2.6M |
| Nov 14, 2025 | CABA | Cabaletta Bio, Inc. | Citadel Advisors LLC | 13G/A | 3.1% | 2.9M |
| Nov 14, 2025 | IMA | ImageneBio, Inc. | BIOTECHNOLOGY VALUE FUND L P | 13G/A | 3.7% | 416K |
| Nov 14, 2025 | MACI | Melar Acquisition Corp. I/Cayman | KARPUS MANAGEMENT, INC. | 13G/A | 5.3% | 1.1M |
| Nov 14, 2025 | SLXN | Silexion Therapeutics Corp | Lind Global Fund III LP | 13G/A | 6.4% | 213K |
| Nov 14, 2025 | BBOT | BridgeBio Oncology Therapeutics, Inc. | Citadel Advisors LLC | 13G/A | 3.2% | 2.5M |
| Nov 14, 2025 | PPHP | PHP Ventures Acquisition Corp. | Meteora Capital, LLC | 13G/A | 6.3% | 73K |
| Nov 14, 2025 | ZEPP | Zepp Health Corp | Point72 Asset Management, L.P. | 13G/A | 7.6% | 8.8M |
| Nov 14, 2025 | KVAC | Keen Vision Acquisition Corp. | KARPUS MANAGEMENT, INC. | 13G/A | 13.4% | 1.2M |
| Nov 14, 2025 | FLYYQ | Spirit Aviation Holdings Inc | AllianceBernstein L.P. | 13G | 9.0% | 2.4M |
| Nov 14, 2025 | BNGO | Bionano Genomics, Inc. | Lind Global Fund III LP | 13G/A | 9.9% | 514K |
| Nov 14, 2025 | ARVN | Arvinas, Inc. | D. E. Shaw & Co., L.P. | 13G | 5.3% | 3.4M |
| Nov 14, 2025 | QURE | uniQure N.V. | Vestal Point Capital, LP | 13G/A | 0.4% | 225K |
| Nov 14, 2025 | BKKT | Bakkt Holdings, Inc. | Citadel Advisors LLC | 13G/A | 0.2% | 28K |
| Nov 14, 2025 | TDOC | Teladoc Health, Inc. | Point72 Asset Management, L.P. | 13G/A | 3.3% | 5.8M |
| Nov 14, 2025 | SRPT | Sarepta Therapeutics, Inc. | D. E. Shaw & Co., L.P. | 13G/A | 1.9% | 2.0M |